Whats new

Whats new.

Jefferies - Phase 2B 1L HNSCC update – ORR in CPS <1 improves c9%; Buy, A$0.93 PT (Analyst: Dr David Stanton)

July 11th 2024

For a copy of this research report please contact your Jefferies advisor